CN112225893B - Porphyrin and hydantoin-based porous organic polymer and preparation method and application thereof - Google Patents
Porphyrin and hydantoin-based porous organic polymer and preparation method and application thereof Download PDFInfo
- Publication number
- CN112225893B CN112225893B CN202010948748.XA CN202010948748A CN112225893B CN 112225893 B CN112225893 B CN 112225893B CN 202010948748 A CN202010948748 A CN 202010948748A CN 112225893 B CN112225893 B CN 112225893B
- Authority
- CN
- China
- Prior art keywords
- hydantoin
- feppop
- porous organic
- organic polymer
- mmol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical compound O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 title claims abstract description 131
- 229920000620 organic polymer Polymers 0.000 title claims abstract description 28
- 150000004032 porphyrins Chemical class 0.000 title claims abstract description 16
- 229940091173 hydantoin Drugs 0.000 title claims abstract description 14
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 239000003242 anti bacterial agent Substances 0.000 claims abstract description 17
- 239000002245 particle Substances 0.000 claims abstract description 5
- 239000012798 spherical particle Substances 0.000 claims abstract description 5
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 24
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 22
- 238000006243 chemical reaction Methods 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 15
- VRLDVERQJMEPIF-UHFFFAOYSA-N dbdmh Chemical compound CC1(C)N(Br)C(=O)N(Br)C1=O VRLDVERQJMEPIF-UHFFFAOYSA-N 0.000 claims description 14
- 102000004190 Enzymes Human genes 0.000 claims description 13
- 108090000790 Enzymes Proteins 0.000 claims description 13
- 235000019260 propionic acid Nutrition 0.000 claims description 11
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims description 11
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 10
- 239000000178 monomer Substances 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 8
- 239000000243 solution Substances 0.000 claims description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 7
- 238000005406 washing Methods 0.000 claims description 7
- JRTIUDXYIUKIIE-KZUMESAESA-N (1z,5z)-cycloocta-1,5-diene;nickel Chemical compound [Ni].C\1C\C=C/CC\C=C/1.C\1C\C=C/CC\C=C/1 JRTIUDXYIUKIIE-KZUMESAESA-N 0.000 claims description 6
- VYXHVRARDIDEHS-UHFFFAOYSA-N 1,5-cyclooctadiene Chemical compound C1CC=CCCC=C1 VYXHVRARDIDEHS-UHFFFAOYSA-N 0.000 claims description 6
- 239000004912 1,5-cyclooctadiene Substances 0.000 claims description 6
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical compound N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 claims description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 239000011259 mixed solution Substances 0.000 claims description 6
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 claims description 5
- 229910052786 argon Inorganic materials 0.000 claims description 5
- 239000011261 inert gas Substances 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 4
- 238000006880 cross-coupling reaction Methods 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 238000000746 purification Methods 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 3
- 239000004599 antimicrobial Substances 0.000 claims description 2
- 239000012298 atmosphere Substances 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 238000001291 vacuum drying Methods 0.000 claims description 2
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 27
- 241000894006 Bacteria Species 0.000 abstract description 22
- 230000003197 catalytic effect Effects 0.000 abstract description 16
- 239000000463 material Substances 0.000 abstract description 16
- 230000001580 bacterial effect Effects 0.000 abstract description 7
- 230000009286 beneficial effect Effects 0.000 abstract description 6
- 230000006378 damage Effects 0.000 abstract description 6
- 238000002474 experimental method Methods 0.000 abstract description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract description 4
- 239000012528 membrane Substances 0.000 abstract description 4
- 239000001301 oxygen Substances 0.000 abstract description 4
- 229910052760 oxygen Inorganic materials 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 4
- 230000000694 effects Effects 0.000 description 14
- 229940088598 enzyme Drugs 0.000 description 12
- 241000191967 Staphylococcus aureus Species 0.000 description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- 239000003642 reactive oxygen metabolite Substances 0.000 description 8
- 238000004833 X-ray photoelectron spectroscopy Methods 0.000 description 7
- 230000007246 mechanism Effects 0.000 description 7
- 239000000758 substrate Substances 0.000 description 7
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 210000000170 cell membrane Anatomy 0.000 description 6
- 239000002086 nanomaterial Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 229910052799 carbon Inorganic materials 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 102000003992 Peroxidases Human genes 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000009792 diffusion process Methods 0.000 description 4
- 108040007629 peroxidase activity proteins Proteins 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 230000002195 synergetic effect Effects 0.000 description 4
- 208000035143 Bacterial infection Diseases 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 208000022362 bacterial infectious disease Diseases 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 239000002149 hierarchical pore Substances 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 229910052982 molybdenum disulfide Inorganic materials 0.000 description 3
- 239000002105 nanoparticle Substances 0.000 description 3
- 230000001699 photocatalysis Effects 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- YIROYDNZEPTFOL-UHFFFAOYSA-N 5,5-Dimethylhydantoin Chemical compound CC1(C)NC(=O)NC1=O YIROYDNZEPTFOL-UHFFFAOYSA-N 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 description 2
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 2
- 238000004566 IR spectroscopy Methods 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 229940124350 antibacterial drug Drugs 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 231100000517 death Toxicity 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 235000019420 glucose oxidase Nutrition 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000003278 mimic effect Effects 0.000 description 2
- 229910052961 molybdenite Inorganic materials 0.000 description 2
- 239000007777 multifunctional material Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 238000000985 reflectance spectrum Methods 0.000 description 2
- 238000004088 simulation Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000002411 thermogravimetry Methods 0.000 description 2
- UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 1
- ZBQCCTCQUCOXBO-UHFFFAOYSA-N 4-(4-aminophenyl)-2,2,6,6-tetramethylcyclohex-3-en-1-amine Chemical compound CC1(C)C(N)C(C)(C)CC(C=2C=CC(N)=CC=2)=C1 ZBQCCTCQUCOXBO-UHFFFAOYSA-N 0.000 description 1
- 108020000946 Bacterial DNA Proteins 0.000 description 1
- 125000006416 CBr Chemical group BrC* 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 238000003775 Density Functional Theory Methods 0.000 description 1
- 238000001157 Fourier transform infrared spectrum Methods 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000003421 catalytic decomposition reaction Methods 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 229910000422 cerium(IV) oxide Inorganic materials 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- -1 concentrated at 1.5 Chemical compound 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000005384 cross polarization magic-angle spinning Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 238000002189 fluorescence spectrum Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 1
- 239000002082 metal nanoparticle Substances 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- CWQXQMHSOZUFJS-UHFFFAOYSA-N molybdenum disulfide Chemical compound S=[Mo]=S CWQXQMHSOZUFJS-UHFFFAOYSA-N 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 239000011943 nanocatalyst Substances 0.000 description 1
- 239000002070 nanowire Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- 230000005311 nuclear magnetism Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- 238000000371 solid-state nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000002336 sorption--desorption measurement Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000001757 thermogravimetry curve Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/0605—Polycondensates containing five-membered rings, not condensed with other rings, with nitrogen atoms as the only ring hetero atoms
- C08G73/0616—Polycondensates containing five-membered rings, not condensed with other rings, with nitrogen atoms as the only ring hetero atoms with only two nitrogen atoms in the ring
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/18—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms
- B01J31/1805—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms the ligands containing nitrogen
- B01J31/181—Cyclic ligands, including e.g. non-condensed polycyclic ligands, comprising at least one complexing nitrogen atom as ring member, e.g. pyridine
- B01J31/184—Cyclic ligands, including e.g. non-condensed polycyclic ligands, comprising at least one complexing nitrogen atom as ring member, e.g. pyridine mixed aromatic/aliphatic ring systems, e.g. indoline
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J35/00—Catalysts, in general, characterised by their form or physical properties
- B01J35/40—Catalysts, in general, characterised by their form or physical properties characterised by dimensions, e.g. grain size
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J35/00—Catalysts, in general, characterised by their form or physical properties
- B01J35/60—Catalysts, in general, characterised by their form or physical properties characterised by their surface properties or porosity
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/02—Compositional aspects of complexes used, e.g. polynuclearity
- B01J2531/0238—Complexes comprising multidentate ligands, i.e. more than 2 ionic or coordinative bonds from the central metal to the ligand, the latter having at least two donor atoms, e.g. N, O, S, P
- B01J2531/0241—Rigid ligands, e.g. extended sp2-carbon frameworks or geminal di- or trisubstitution
- B01J2531/025—Ligands with a porphyrin ring system or analogues thereof, e.g. phthalocyanines, corroles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/84—Metals of the iron group
- B01J2531/842—Iron
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Materials Engineering (AREA)
- Health & Medical Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Catalysts (AREA)
Abstract
The invention provides a porous organic polymer based on porphyrin and hydantoin, and a preparation method and application thereof, and belongs to the technical field of porous organic polymers. The porous organic polymer is composed of spherical particles with the particle size being aggregated within the range of 200-300 nm. The porous organic polymer of the invention has positive charges, is more beneficial to interact with negatively charged bacteria so as to enable the bacteria to be combined on a bacterial membrane, and is beneficial to eliminating the bacteria within the damage range of active oxygen. Meanwhile, the porphyrin and hydantoin units and the enlarged conjugated structures thereof enable the material to have excellent peroxidase-like catalytic activity, near-infrared enhanced light Fenton performance and chemical antibacterial activity, and have good reusability. Proved by experiments, under the near infrared irradiation, FePPOPHydantoinThe antibacterial efficiency of the antibacterial agent is over 99.999 percent. Meanwhile, the material preparation method is simple and has strong controllability, so that the material has good practical application value.
Description
Technical Field
The invention belongs to the technical field of porous organic polymers, and particularly relates to a porous organic polymer based on porphyrin and hydantoin, and a preparation method and application thereof.
Background
The information in this background section is only for enhancement of understanding of the general background of the invention and is not necessarily to be construed as an admission or any form of suggestion that this information forms the prior art that is already known to a person of ordinary skill in the art.
Bacterial infections are an increasingly serious health problem worldwide. Antibiotics are considered the most widely accepted therapeutic measures. However, bacteria have begun to develop resistance to antibiotics due to overuse and abuse. Antibiotic resistance causes about 70 million deaths worldwide each year, becoming a huge economic burden impeding social development, especially in underdeveloped countries. Therefore, the development of efficient novel antibacterial drugs, particularly antibacterial drugs with low drug resistance tendency, is very important for preventing and treating bacterial infection.
To date, alternative nanomaterial designs for antimicrobial applications have been developedA great deal of effort is expended. Different from the traditional antibiotics for preserving the form of bacteria, the nano material has a multi-modal antibacterial effect, and the nano material has good stability, is easy to manufacture and reuse, so that the drug resistance is not easy to generate. The cell membrane of the whole bacterium can be completely decomposed by the treatment of the nano material. Therefore, it is difficult for bacteria to repair physically damaged cell membranes, thereby slowing down the evolution of antibacterial resistance. To date, a large number of nanomaterials, such as metal oxide nanoparticles, noble metal nanoparticles and transition metals, have been reported to exhibit good antibacterial properties. Among them, nanoenzymes provide unprecedented opportunities for antibacterial activity. They gain inspiration from the natural antibacterial mechanism and can catalyze H2O2Converted into highly toxic Reactive Oxygen Species (ROS) and cause irreversible damage to bacteria. E.g. Fe3O4Nanoparticles of V2O5Nanowires, nitrogen-doped carbon nanomaterials (N-CNMs), CeO2Nanoparticles and the like have been found to be able to combat bacteria with their superior peroxidase mimetic activity.
Despite their promising antibacterial applications, nanoenzymes still face some challenges. First, some nanoenzymes are toxic, which prevents their widespread use. Secondly, the diffusion distance of ROS is about 20nm, and its lifetime is less than 200 ns. Unfortunately, most nanoenzymes do not effectively capture bacteria within the effective range of reactive oxygen species damage, thereby reducing their effect against bacteria. Third, nanoenzymes typically have lower catalytic efficiency than native enzymes, exhibiting pH-dependent catalytic properties. Thus, to obtain a sufficiently high concentration of ROS, a higher concentration of H is required2O2. These fatal defects limit their use in biological systems where the pH is neutral, allowing H2O2The highest biologically relevant concentration was 100. mu.M. To address these challenges faced by nanoenzymes, a typical strategy is to construct multifunctional materials with synergistic effects. For example, the just-in-the-morning task group reported a positively charged microporous MoS2The hydrogel can capture bacteria in the damage range of active oxygen. In addition, in combination with the photothermal effect of the molybdenum disulfide,achieve the synergistic sterilization effect. To avoid direct use of high concentrations of toxic H2O2A self-activating (2D Cu-TCPP (Fe)/GOx) nano-catalyst is prepared. The glucose oxidase can convert glucose into gluconic acid and H2O2Not only can provide rich H2O2And the pH value of the system can be reduced to 3-4, so that the antibacterial efficiency of the 2D Cu-TCPP (Fe) is obviously improved. Au/g-C is also reported3N4Multifunctional material, and MoS2@ PDA-Ag and the like are against bacteria. Despite these tremendous advances, new and effective strategies against bacteria remain urgently needed.
Among many reported biological systems, porphyrins have good biocompatibility and efficient catalytic performance, and are typical representatives of functional molecular materials. In recent years, porphyrin-based porous organic polymers (POPPs) have become one of the most interesting nanoenzymology. Due to the following advantages: 1) the POPPs as a porous material has larger surface area, hierarchical pore structure and abundant surface active sites, and is beneficial to H2O2Close to the active site and diffusion of ROS. 2) POPPs can be given a variety of structures and functions due to the modifiable nature of the structure. However, the inventors found that, to date, studies on the activity of POPPs peroxidase-like enzymes have been mainly focused on biosensors, but since strong acidic conditions are also required for optimal expression of peroxidase-like enzyme activity, there are few people who apply it to the biomedical field.
Disclosure of Invention
In order to overcome the technical problems, the invention provides a porous organic polymer FePPOP based on porphyrin and hydantoinHydantoinThe invention utilizes cross-coupling reaction to construct FePPOP (FePPOP)HydantoinIt has a positive charge, facilitating its interaction with negatively charged bacteria and thus binding to the bacterial membrane, facilitating bacterial clearance in the range of reactive oxygen species destruction. At the same time, FePPOPHydantoinThe porphyrin and hydantoin units and the enlarged conjugated structure thereof enable the material to have excellent peroxidase-like catalytic activity and near-infrared enhanced light Fenton performanceChemical antibacterial activity, thus having good practical application value.
In order to achieve the technical purpose, the technical scheme adopted by the invention is as follows:
in a first aspect of the invention, a porous organic polymer FePPOP based on porphyrin and hydantoin is providedHydantoinHaving a repeating structural unit represented by the following formula I,
in a second aspect of the present invention, there is provided the above-mentioned porous organic polymer FePPOPHydantoinThe production method of (2), the production method comprising: the compound is prepared by taking 1, 3-dibromo-5, 5-dimethylhydantoin and a monomer 5,10,15, 20-tetra (4-bromophenyl) ferriporphyrin (FeTBrPP) as raw materials based on cross-coupling reaction.
In a third aspect of the present invention, there is provided the above-mentioned porous organic polymer FePPOPHydantoinUse in any one of:
1) antibacterial agents and/or preparation of antibacterial agents;
2) nano enzyme and/or nano enzyme preparation.
In a fourth aspect of the present invention, there is provided an antibacterial agent comprising the above-mentioned porous organic polymer, FePPOPHydantoinThe antibacterial agent can exhibit bacteriostatic and bactericidal effects on various bacteria including staphylococcus aureus.
In a fifth aspect of the invention, a nanoenzyme is provided, wherein the nanoenzyme comprises the porous organic polymer FePPOPHydantoinThe nano enzyme has peroxidase mimic activity.
In a sixth aspect of the present invention, there is provided a bacteriostasis and/or sterilization method, comprising: adding the porous organic polymer FePPOP into a sample to be treatedHydantoinAntibacterial agents and/or nanoenzymes.
The beneficial technical effects of one or more technical schemes are as follows:
as described aboveThe technical scheme is that a porous porphyrin-based organic polymer FePPOP with positive charge is prepared for the first timeHydantoinIt is more favorable for interacting with negatively charged bacteria to bind on the bacterial membrane, and is favorable for eliminating bacteria in the damage range of active oxygen. Meanwhile, the porphyrin and hydantoin units and the enlarged conjugated structures thereof enable the material to have excellent peroxidase-like catalytic activity, near-infrared enhanced light Fenton performance and chemical antibacterial activity, and have good reusability. Through test verification, under near infrared irradiation, FePPOPHydantoinThe antibacterial efficiency of the antibacterial agent is over 99.999 percent. Meanwhile, the material preparation method is simple and has strong controllability, so that the material has good practical application value.
Drawings
The accompanying drawings, which are incorporated in and constitute a part of this specification, are included to provide a further understanding of the invention, and are incorporated in and constitute a part of this specification, illustrate exemplary embodiments of the invention and together with the description serve to explain the invention and not to limit the invention.
FIG. 1 shows FePPOP prepared by the example of the present inventionHydantoinThe infrared spectrogram of (1) is shown in the specification, wherein a is Hydantoin, b is FeTBrPP, and c is FePPOPHydantoin；
FIG. 2 shows FePPOP prepared by the embodiment of the present inventionHydantoinA solid carbon spectrum of (a);
FIG. 3 shows FePPOP prepared by the embodiment of the present inventionHydantoinThermogravimetric analysis curve of (a);
FIG. 4 shows FePPOP prepared by the embodiment of the present inventionHydantoinScanning electron microscope pictures;
FIG. 5 shows FePPOP prepared according to an embodiment of the present inventionHydantoinThe nitrogen adsorption and desorption curve diagram;
FIG. 6 shows FePPOP prepared by the example of the present inventionHydantoinWherein A is FePPOPHydantoinThe ultraviolet-visible absorption spectrogram of Hydantoin and FeTBrPP, B is FePPOPHydantoinThe band gap energy spectrum schematic diagram C is FePPOPHydantoinHydantoin and FeTBrPP fluorescence spectrograms, D is FePPOPHydantoinGraph of photocurrent versus time;
FIG. 7 shows FePPOP prepared by the example of the present inventionHydantoinThe peroxidase activity condition of (1) is a characteristic diagram, wherein A is a transformation diagram of TMB and oxTMB, and B is FePPOP under different conditionsHydantoinC is FePPOPHydantoinD is H2O2Concentration, E is pH, F is temperature;
FIG. 8 shows FePPOP prepared by the present inventionHydantoinA is H2O2The curve of the initial velocity of the substrate and the concentration of the substrate, B is a simulation standard curve of the initial velocity of A and the double reciprocal of the concentration of the substrate, C is a curve of the initial velocity of the TMB substrate and the concentration of the substrate, and D is a simulation standard curve of the initial velocity of C and the double reciprocal of the concentration of the substrate;
FIG. 9 shows FePPOP prepared by an embodiment of the present inventionHydantoinThe photo-Fenton activity test chart of (1);
FIG. 10 shows FePPOP prepared by an embodiment of the present inventionHydantoinZeta potential test chart and antibacterial activity chart of (1); wherein, A is a Zeta potential test chart, and B is an antibacterial activity chart;
FIG. 11 shows FePPOP prepared by the example of the present inventionHydantoinWherein A is FePPOPHydantoinXPS graph before use, B is FePPOPHydantoinXPS graph after use, C is FePPOPHydantoinXPS plot of O1s before use, plot D is FePPOPHydantoinXPS plots of post-use O1 s;
FIG. 12 shows FePPOP prepared according to an embodiment of the present inventionEPAInfrared spectrograms before and after use;
FIG. 13 is an SEM image of Staphylococcus aureus treated under different conditions, wherein A is PBS and B is H2O2C is FePPOPHydantoinD is FePPOPHydantoin+ NIR, E is FePPOPHydantoin+H2O2F is FePPOPHydantoin+H2O2+NIR。
Detailed Description
It is to be understood that the following detailed description is exemplary and is intended to provide further explanation of the invention as claimed. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.
It is noted that the terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of exemplary embodiments according to the invention. As used herein, the singular forms "a", "an" and "the" are intended to include the plural forms as well, and it should be understood that when the terms "comprises" and/or "comprising" are used in this specification, they specify the presence of stated features, steps, operations, devices, components, and/or combinations thereof, unless the context clearly indicates otherwise. It is to be understood that the scope of the invention is not to be limited to the specific embodiments described below; it is also to be understood that the terminology used in the examples is for the purpose of describing particular embodiments only, and is not intended to limit the scope of the present invention.
As mentioned previously, porphyrins have good biocompatibility and efficient catalytic properties and are typical representatives of functional molecular materials. However, studies on the activity of POPPs peroxidase-like enzymes have so far focused on biosensors, but since strong acidic conditions are also required for optimal expression of peroxidase-like activities, few have been applied to the biomedical field.
On the other hand, 1, 3-dibromo-5, 5' dimethylhydantoin has attracted considerable interest as an antibiotic. Studies have shown that they exhibit low bacterial resistance, probably because they have a mixed multi-modal biocidal mechanism of destroying bacterial DNA, interfering with cellular metabolism by reacting with cellular material, etc. However, having only moderate antibacterial activity will seriously affect its practical application. Therefore, it is necessary to combine other antibacterial groups with 1, 3-dibromo-5, 5' dimethylhydantoin to overcome the inefficiency, minimize the risk of undesirable effects, and achieve synergistic antibacterial performance. In addition, the polymer structure containing hydantoin functional groups is more stable than the monomer structure from a recycling point of view.
Based on the above consideration, the present invention prepares positively charged porous porphyrin-based organic polymerization for the first timeSubstance FePPOPHydantoinIt can be used as an effective antibacterial agent. Thus, in one embodiment of the present invention, there is provided a porphyrin and hydantoin based porous organic polymer, FePPOPHydantoinWhich is composed of spherical particles with the particle diameter of 200-300 nm, has good thermal stability, and has a repeating structural unit shown in the following formula I,
in still another embodiment of the present invention, there is provided the above porous organic polymer, FePPOPHydantoinThe production method of (2), the production method comprising: the compound is prepared by taking 1, 3-dibromo-5, 5-dimethylhydantoin and a monomer 5,10,15, 20-tetra (4-bromophenyl) ferriporphyrin (FeTBrPP) as raw materials based on cross-coupling reaction.
Wherein the molar ratio of the 1, 3-dibromo-5, 5-dimethylhydantoin to the FeTBrPP is 0.5-5: 1, such as 0.5: 1. 1: 1. 2: 1. 5: 1, more preferably 0.47: 0.24;
specifically, the preparation method comprises the following steps: under the atmosphere of inert gas, 1, 3-dibromo-5, 5-dimethylhydantoin and FeTBrPP are placed in a mixed solution for heating; and (3) after the heating reaction is finished, adding propionic acid into the solution, and stirring and purifying to obtain the propionic acid.
Wherein the inert gas is nitrogen or argon, preferably argon;
the mixed solution is a mixture of 2, 2' -bipyridine, bis (1, 5-cyclooctadiene) nickel (0), 1, 5-cyclooctadiene and N, N-Dimethylformamide (DMF), and is used when the mixed solution is purple after being stirred.
Wherein the molar volume ratio of the 2, 2' -bipyridine to the bis (1, 5-cyclooctadiene) nickel (0) to the 1, 5-cyclooctadiene to DMF is 1-5 mmol: 1-5 mmol: 1-4 mmol: 50-100 mL; preferably 4.09 mmol: 4.09 mmol: 3.96 mmol: 65 mL.
The heating reaction specifically comprises the following steps: reacting for 1-15 h at 70-90 ℃, preferably for 12h at 80 ℃; by controlling the heating temperature and time, the reaction progress is accelerated, and the yield is improved.
The molar volume ratio of FeTBrPP to DMF to propionic acid is 0.1-0.5 mmol: 50-100 mL: 5-15 mL; preferably 0.24 mmol: 65mL of: 10 mL.
The propionic acid is added in a stirring mode, and the stirring time is controlled to be 0.1-1 h, preferably 0.5 h.
The purification step includes filtration, washing and drying.
The washing method comprises the following specific steps: washing with chloroform, tetrahydrofuran and water respectively;
the drying method comprises the following specific steps: and (3) carrying out vacuum drying on the washed product at 70-90 ℃.
In still another embodiment of the present invention, there is provided the above porous organic polymer, FePPOPHydantoinUse in any one of:
1) antibacterial agents and/or preparation of antibacterial agents;
2) nano enzyme and/or nano enzyme preparation.
In yet another embodiment of the present invention, there is provided an antimicrobial agent comprising the above-described porous organic polymer, FePPOPHydantoinThe antibacterial agent can exhibit bacteriostatic and bactericidal effects on various bacteria including staphylococcus aureus.
In another embodiment of the present invention, there is provided a nanoenzyme comprising the above porous organic polymer, FePPOPHydantoinThe nano enzyme has peroxidase mimic activity.
In another embodiment of the present invention, there is provided a method of bacteriostasis and/or sterilization, comprising: adding the porous organic polymer FePPOP into a sample to be treatedHydantoinAntibacterial agents and/or nanoenzymes.
In another embodiment of the present invention, the method further comprises irradiating the sample to be treated with near infrared light and/or adding H to the sample to be treated2O2。
The present invention will be further described with reference to specific examples for better illustrating the objects, technical solutions and advantages of the present invention.
Examples
HydantoinFePPOP material synthesis
1) Synthesis of monomer 5,10,15, 20-tetrakis (4-bromophenyl) ferriporphyrin (FeTBrPP):
in a 250mL three-necked flask, H is added2TBrPP (300mg,0.32mmol) was dissolved in 150mL DMF and FeCl was added3·6H2O (60.48mg,0.37mmol), was heated to reflux with stirring for 4 h. Then distilling under reduced pressure to remove DMF solvent, cooling to room temperature, adding a large amount of water for washing, and filtering to remove FeCl3Until the wash solution is colorless, at which point the filter cake is purple, i.e., the monomer 5,10,15, 20-tetrakis (4-bromophenyl) ferriporphyrin (MALDI-TOF MS: calcd. for C)44H26Br4N4Fe[M+H]+:983.06；found m/z 986.32)。
2)FePPOPHydantoinPreparation of
FePPOPHydantoinThe preparation of (A) is carried out in two stages. One is a reaction process in the glove box and the other is a post-treatment process. 2, 2' -bipyridine (0.64g,4.09mmol), bis (1, 5-cyclooctadiene) nickel (0) (1.13g,4.09mmol) and 1, 5-cyclooctadiene (0.5mL,3.96mmol) were first dissolved in dry DMF (65mL) and stirred to purple. 1, 3-dibromo-5, 5-dimethylhydantoin (134.66mg,0.47mmol) and iron (III)5,10,15, 20-tetrabromo- (4' -bromophenyl) porphyrin (FeTBrPP,232.40mg,0.24mmol) were mixed with the above solution, and the temperature was maintained at 80 ℃. The solution was kept at this temperature for 12 hours under argon protection and then allowed to cool naturally. A defined amount of 10mL of propionic acid was gradually added to the purple suspension, stirred for 0.5h and filtered to give the crude product. Then washed with chloroform, tetrahydrofuran and water, respectively, to give the product, the reaction formula is shown below, and finally the black solid was dried in a vacuum oven at 80 ℃ (yield 78.1%).
HydantoinFePPOP infrared spectroscopy and solid nuclear magnetism characterization
It was first characterized by infrared spectroscopy. Compared with the monomer, the C-Br and N-Br stretching vibration of FeTBrPP and 1, 3-dibromo-5, 5-dimethylhydantoin respectively appears at 467cm-1And 720cm-1Almost disappeared after polymerization, indicating that the monomer had been completely condensed, FIG. 1. At the same time, the main fingerprint peaks of the monomers were observed in the polymer. At 2960cm-1And 1640cm-1In which-CH of 1, 3-dibromo-5, 5-dimethylhydantoin is present3And C-H and C ═ O vibrate telescopically. At 1001cm-1The peak is caused by the N-Fe stretching vibration band formed by FeTBrPP. In addition, use is made of13FePPOP was further verified by C CP/MAS solid-state NMRHydantoinFIG. 2. The characteristic peaks δ of 20ppm and δ of 60ppm can be assigned to CH in 1, 3-dibromo-5, 5-dimethylhydantoin3And sp3 hybridized carbon. The peaks centered at 162ppm and 180ppm are due to the C ═ O group of the methoxy group. And FePPOPHydantoinThe aromatic carbon in the medium from FeTBrPP reaches a peak value between 109 and 159 ppm. From the above results, it can be seen that 1, 3-dibromo-5, 5-dimethylhydantoin and FeTBrPP maintain the desired structures in the polymer.
HydantoinThe stability and the morphology of FePPOP are characterized as follows:
the thermogravimetric analysis (TGA) results show that the compound has good heat resistance. In N2Under the protection of (3), when the temperature reaches 100 ℃, the weight loss rate is only 7.02 percent, as shown in figure 3. FePPOPHydantoinHas good stability, which is probably related to more nitrogen-containing groups. The high stability ensures FePPOPHydantoinCan bear severe environmental conditions. FIG. 4 is a diagram of synthetic FePPOPHydantoinThe morphological characteristics of (1). FePPOPHydantoinIs composed of spherical particles with the particle size of 200-300 nm. It was further observed that the particle surface was clearly rough, which may be the result of aggregation of spherical particles.
HydantoinPorosity characterization of FePPOP
FIG. 5 shows FePPOPHydantoinThe inner graph is a pore diameter distribution graph. Adsorption of nitrogen gas at different pressure ranges confirmed FePPOPHydantoinSatisfying a combination of type I and type iv adsorption isotherms. FePPOP materialHydantoinHas a Brunauer-Emmett-Teller (BET) surface area of 301.41m2 g-1And through the calculation of a non-density functional theory, FePPOPHydantoinMainly concentrated at 1.5, 5, 9nm, which fully demonstrates the FePPOPHydantoinThe hierarchical pore structure of (1). The high BET surface area and hierarchical pore structure provide rich active sites for peroxidase-like performance, facilitating accessibility and diffusion of reactants and products to catalytic centers.
HydantoinOptical property characterization of FePPOP
Research of FePPOP by using ultraviolet-visible diffuse reflectance spectrum, fluorescence spectrum and photocurrentHydantoinSee fig. 6. 1, 3-dibromo-5, 5-dimethylhydantoin monomer (Hydantoin) absorbs light having a wavelength of 272 nm. The FeTBrPP shows a strong and narrow absorption band only at the wavelength 417nm, both with relatively low efficiency for visible light, fig. 6, a. After polymerization, the absorption edge is sharply broadened and the absorption tail extends to 1000 nm. In combination with a narrow band gap (1.06eV) estimated based on the starting wavelength of the uv diffuse reflectance spectrum, this clearly means that the dipyrrolidone can utilize more visible and near infrared light to enhance its photocatalytic activity, thanks to the extended coupled framework, fig. 6, B. In addition, FePPOPHydantoinThe fluorescence response is obviously weakened, and fig. 6 and C show that the recombination rate of the photoexcited electron-hole pair is reduced, which is beneficial to FePPOPHydantoinImprove the photocatalytic activity. The photocurrent response test shows that the photocurrent response of the ITO sample is obviously enhanced, the generated photocurrent is about 31nA, and the ITO sample can be repeatedly switched on and off without obvious deterioration, and the graph is shown in figure 6 and D. This may be due to FePPOPHydantoinThe expanded coupling structure not only improves the near infrared absorption capability, but also promotes the mobility of current carriers, thereby slowing down the recombination of charges.
HydantoinPeroxidase Activity of FePPOP
FePPOP was evaluated by oxidation of 3,3,5, 5-Tetramethylbenzidine (TMB) as a colorimetric substrateHydantoinFig. 7, B. With FePPOPHydantoin+TMB、H2O2+ TMB, TMB and other control experiments compared with no color change, FePPOPHydantoinCan be at H2O2When present, accelerated the conversion of TMB to oxTMB, appearing dark blue. FePPOPHydantoinThe large specific surface area and the expanded coupling framework of (2) promote TMB and FePPOP by means of clusteringHydantoinIn combination with (1). And the abundant surface catalytic active sites and the multi-stage porous structure are beneficial to H2O2Accessibility of and diffusion of generated ROS. In addition, FePPOP was recovered by 5 consecutive timesHydantoinSustainability analysis was performed, as shown in fig. 7, C, indicating good recyclability. Further experiments show that FePPOPHydantoinCatalytic performance of with H2O2Concentration, pH and temperature (FIG. 7, D-F) were related, consistent with most peroxidase-like mimetic enzymes reported previously. The best performance occurs at pH 3.77 and 30 ℃ respectively. In addition, FePPOPHydantoinIt also showed 50% catalytic activity at pH 7.0, fig. 7, E, which provides the possibility for its practical application in normal tissues and sites of bacterial infection.
HydantoinReaction kinetics of FePPOP
To better understand FePPOPHydantoinBy fixing TMB concentration and varying H2O2Concentrations were analyzed for steady state kinetics and vice versa. The kinetics of the catalytic reaction is determined by ultraviolet-visible spectrophotometry. The reaction is carried out by maintaining H2O2The Michaelis constant was determined by varying the concentration of TMB (0.5mM) and by maintaining the concentration of TMB and varying the concentration of hydrogen peroxide. Then, a series of initial reaction rates were obtained, as shown in FIG. 8. Km and Vmax are calculated by using a Lineweaver-Burk double reciprocal formula, which is shown as the following formula:
1/v＝(Km/Vmax)×(1/[C])+1/Vmax Eq.(1)
in the formula, V is the initial velocity, C is the substrate concentration, VmaxAnd KmThe maximum reaction rate and the mie constant, respectively. The maximum reaction rate of the material and the mie constant are shown in table 1.
TABLE 1 maximum reaction rates and Mie's constants
Hydantoinphoto-Fenton catalytic activity of FePPOP
The MB is degraded by near infrared radiation, and FePPOP is determinedHydantoinThe photo-Fenton catalytic activity of (1). FePPOP (FePPOP)HydantoinStirring the mixed solution with MB vigorously in dark for 80min to reach adsorption-desorption equilibrium, and adding H2O2Added to the solution and irradiated with 808nm near infrared light. As shown in FIG. 9, about 97% of MB changed color within 40 minutes of irradiation (FePPOPHYydantoin + H)2O2+ NIR group). FePPOP without irradiationHydantoin+H2O2Group, only 66% of MB discoloured at the same time. However, by a series of NIR, H2O2、NIR+H2O2、NIR+FePPOPHydantoinThe control experiment of (2) shows that neither can effectively photodegrade MB. These results clearly demonstrate the FePPOPHydantoinHas excellent photo-Fenton performance such as high specific surface area, abundant active sites, effective near-infrared absorption and the like.
Detection of active oxygen
The photo-assisted fenton process starts with a classical reaction, generating hydroxyl radicals. At the same time, Fe (III) can be converted into Fe (II), possibly in H, with the aid of light2O2With the help of (2), further complete the continuous cycle in Fe (III)/Fe (II). On the other hand, the catalytic properties of peroxidase-like nanoenzymes are generally capable of degrading H2O2Hydroxyl radicals are generated. By using pairsPhthalic acid (TA) was used to verify the catalytic mechanism of the material as an indicator to monitor hydroxyl radical generation. As shown in FIG. 10, A, the fluorescence intensity shows a FePPOPHydantoinConcentration dependence indicates that OH is produced in large amounts. All these results indicate that the FePPOP is due toHydantoinThe light and peroxide properties of (2) significantly enhance catalytic activity.
Antibacterial experiments are carried out on staphylococcus aureus by considering the enzyme catalytic capability and the photocatalytic capability of ferriporphyrin and the chemical antibacterial property of hydantoin. Before the test, FePPOP was monitoredHydantoinZeta potential of (c) to evaluate its antibacterial ability. From FIG. 10, A, it can be seen that the Zeta potential value of the polymer of FeTBrPP is-15.7 mV. However, when Hydantoin cells are introduced into the system, FePPOPHydantoinThe potential value of the positive charge material is obviously improved to +26mV, and the capture efficiency of the bacteria can be effectively improved due to the electronic interaction between the positive charge material and the negative charge bacterial cell membrane. When bacteria react with FePPOPHydantoinAfter combination, the oxidation resistance potential value is obviously reduced, which indicates that FePPOPHydantoinThere is an interaction with staphylococcus aureus. In addition, different concentrations of FePPOPHydantoinAnd the effect of the treatment under different conditions is shown in fig. 10, B.
Mechanism exploration
To clarify the antibacterial mechanism, two antibacterial methods were investigated using X-ray photoelectron spectroscopy (XPS) and fourier transform infrared spectroscopy (FT-IR), as shown in fig. 11 and 12. FePPOPHydantoinThe XPS survey spectra of (a) showed C1s, N1s, O1s, and Fe2p peaks at 284.7, 398.4, 531.7, and 711.2, respectively. Among them, O1s species belong to FePPOPHydantoinHydantoin cell of (1). The peak remains unchanged after sterilization. Binding of FePPOP before and after antibacteriumHydantoinSimilar FT-IR spectrum clearly demonstrates FePPOPHydantoinStability during the antibacterial process. Studies have shown that the antibacterial mechanism of Hydantoin can be divided into contact kill, release kill and transfer kill. Based on the stability of the above structure, the Hydantoin unit antimicrobial mechanism may be contact kill. Meanwhile, SEM pictures are used for revealing gold under different conditionsDamage to the cell membrane of Staphylococcus aureus, as shown in FIG. 13. When FePPOPHydantoinAfter incubation with staphylococcus aureus, FePPOP is foundHydantoinDue to electrostatic interaction, it binds tightly to staphylococcus aureus. With FePPOP separatelyHydantoin、FePPOPHydantoin+ NIR and FePPOPHydantoin+H2O2After incubation, there was a small amount of cell surface disruption, but the outer membrane structure remained unchanged, indicating that these modes were less effective at inhibiting bacteria. FePPOPHydantoin+NIR+H2O2The bacterial surface was more severely damaged by the 20 minute treatment. Demonstration of FePPOPHydantoin+NIR+H2O2The system has synergistic antibacterial ability. In this process, OH generated by the photo-Fenton reaction destroys cell membrane, and the permeability of cell membrane increases, accelerating the growth of nutrient substance and FePPOPHydantoinMedium Hydantoin cell contact. Plus FePPOPHydantoinCatalytic decomposition of H2O2The resulting OH attacks further, leading to bacterial death.
It should be noted that the above-mentioned embodiments are only preferred embodiments of the present invention, and the present invention is not limited thereto, and although the present invention has been described in detail with reference to the foregoing embodiments, it will be apparent to those skilled in the art that modifications and equivalents can be made in the technical solutions described in the foregoing embodiments, or equivalents thereof. Any modification, equivalent replacement, or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention. Although the present invention has been described with reference to the specific embodiments, it should be understood by those skilled in the art that various changes and modifications may be made without departing from the spirit and scope of the invention.
Claims (10)
1. Porphyrin and hydantoin based porous organic polymer FePPOPHydantoinHaving a repeating structural unit represented by the following formula I,
formula I;
which consists of spherical particles with the particle size of 200-300 nm.
2. The porous organic polymer FePPOP as claimed in claim 1HydantoinThe method for producing (a), characterized by comprising: the compound is obtained by taking 1, 3-dibromo-5, 5-dimethylhydantoin and monomer 5,10,15, 20-tetra (4-bromophenyl) ferriporphyrin as raw materials based on cross-coupling reaction.
3. The preparation method according to claim 2, wherein the molar ratio of the 1, 3-dibromo-5, 5-dimethylhydantoin to the FeTBrPP is 0.5 to 5: 1.
4. the process according to claim 3, wherein the molar ratio of 1, 3-dibromo-5, 5-dimethylhydantoin to FeTBrPP is 0.47: 0.24.
5. the method of any one of claims 2 to 4, wherein the method comprises: under the atmosphere of inert gas, 1, 3-dibromo-5, 5-dimethylhydantoin and FeTBrPP are placed in a mixed solution for heating; and (3) after the heating reaction is finished, adding propionic acid into the solution, and stirring and purifying to obtain the propionic acid.
6. The method of claim 5, wherein the inert gas is nitrogen or argon;
the mixed solution is a mixture of 2, 2' -bipyridine, bis (1, 5-cyclooctadiene) nickel (0), 1, 5-cyclooctadiene and N, N-dimethylformamide;
the molar volume ratio of the 2, 2' -bipyridine to the bis (1, 5-cyclooctadiene) nickel (0) to the 1, 5-cyclooctadiene to the N, N-dimethylformamide is 1-5 mmol: 1-5 mmol: 1-4 mmol: 50-100 mL;
the heating reaction is specifically reaction at 70-90 ℃ for 1-15 h;
the mol volume ratio of the FeTBrPP to the N, N-dimethylformamide to the propionic acid is 0.1-0.5 mmol: 50-100 mL: 5-15 mL;
adding propionic acid while stirring, wherein the stirring time is controlled to be 0.1-1 h;
the purification step includes filtration, washing and drying.
7. The method of claim 6, wherein the inert gas is argon;
the molar volume ratio of the 2, 2' -bipyridine to the bis (1, 5-cyclooctadiene) nickel (0) to the 1, 5-cyclooctadiene to the N, N-dimethylformamide is 4.09 mmol: 4.09 mmol: 3.96 mmol: 65 mL;
the heating reaction is specifically carried out for 12 hours at 80 ℃;
the molar volume ratio of the FeTBrPP to the N, N-dimethylformamide to the propionic acid is 0.24 mmol: 65mL of: 10 mL;
the propionic acid is added in a stirring mode, and the stirring time is controlled to be 0.5 h;
the specific washing method in the purification step comprises the following steps: washing with chloroform, tetrahydrofuran and water respectively;
the drying method in the purification step comprises the following steps: and (3) carrying out vacuum drying on the washed product at 70-90 ℃.
8. The porous organic polymer FePPOP as claimed in claim 1HydantoinUse in any one of:
1) preparing an antibacterial agent;
2) and (4) preparing the nano enzyme.
9. An antimicrobial agent comprising the porous organic polymer of claim 1, FePPOPHydantoin。
10. A nanoenzyme comprising the porous organic polymer FePPOP of claim 1Hydantoin。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010948748.XA CN112225893B (en) | 2020-09-10 | 2020-09-10 | Porphyrin and hydantoin-based porous organic polymer and preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010948748.XA CN112225893B (en) | 2020-09-10 | 2020-09-10 | Porphyrin and hydantoin-based porous organic polymer and preparation method and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN112225893A CN112225893A (en) | 2021-01-15 |
| CN112225893B true CN112225893B (en) | 2022-05-03 |
Family
ID=74115671
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010948748.XA Active CN112225893B (en) | 2020-09-10 | 2020-09-10 | Porphyrin and hydantoin-based porous organic polymer and preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112225893B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114436338B (en) * | 2022-03-01 | 2023-07-25 | 青岛大学 | Fe-Mo bimetallic nano-enzyme and preparation method and application thereof |
| CN115999641B (en) * | 2022-08-29 | 2023-08-15 | 山东万博环境治理有限公司 | CeO (CeO) 2 Cu-TCPP composite photocatalyst and preparation method and application thereof |
| CN115818623B (en) * | 2022-12-09 | 2024-02-23 | 山东大学 | Folic acid-iron porphyrin carbonized polymer dot and preparation method and application thereof |
| CN116003820B (en) * | 2023-02-15 | 2023-12-19 | 山东大学 | Palladium porphyrin and triptycene-based porous organic polymer, and preparation method and application thereof |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4935147A (en) * | 1985-12-20 | 1990-06-19 | Syntex (U.S.A.) Inc. | Particle separation method |
| CN105613506A (en) * | 2016-03-22 | 2016-06-01 | 江南大学 | Haloamine/quaternary ammonium olefin antibacterial agent and application of antibacterial agent to biodegradable nanofiber material |
| CN107335458A (en) * | 2017-07-06 | 2017-11-10 | 华东师范大学 | A kind of preparation method of nitrogen-doped carbon and iron nitrogen-phosphor codoping carbon electrocatalysis material |
| CN109126877A (en) * | 2018-09-20 | 2019-01-04 | 西北师范大学 | A kind of preparation and application of iron (III) tetracarboxylic phenyl porphyrin implanted metal organic frame |
| CN109682804A (en) * | 2019-02-01 | 2019-04-26 | 中南民族大学 | A kind of nanometer of porphyrin catalyst and the method for being catalyzed TMB colour developing using it |
| CN110194824A (en) * | 2019-07-03 | 2019-09-03 | 江南大学 | A kind of porphyryl is from tool microporous polymer and its synthetic method |
| CN110746602A (en) * | 2019-10-29 | 2020-02-04 | 大连理工大学 | Metal cobalt porphyrin-based porous organic polymer and preparation method and application thereof |
-
2020
- 2020-09-10 CN CN202010948748.XA patent/CN112225893B/en active Active
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4935147A (en) * | 1985-12-20 | 1990-06-19 | Syntex (U.S.A.) Inc. | Particle separation method |
| CN105613506A (en) * | 2016-03-22 | 2016-06-01 | 江南大学 | Haloamine/quaternary ammonium olefin antibacterial agent and application of antibacterial agent to biodegradable nanofiber material |
| CN107335458A (en) * | 2017-07-06 | 2017-11-10 | 华东师范大学 | A kind of preparation method of nitrogen-doped carbon and iron nitrogen-phosphor codoping carbon electrocatalysis material |
| CN109126877A (en) * | 2018-09-20 | 2019-01-04 | 西北师范大学 | A kind of preparation and application of iron (III) tetracarboxylic phenyl porphyrin implanted metal organic frame |
| CN109682804A (en) * | 2019-02-01 | 2019-04-26 | 中南民族大学 | A kind of nanometer of porphyrin catalyst and the method for being catalyzed TMB colour developing using it |
| CN110194824A (en) * | 2019-07-03 | 2019-09-03 | 江南大学 | A kind of porphyryl is from tool microporous polymer and its synthetic method |
| CN110746602A (en) * | 2019-10-29 | 2020-02-04 | 大连理工大学 | Metal cobalt porphyrin-based porous organic polymer and preparation method and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN112225893A (en) | 2021-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112225893B (en) | Porphyrin and hydantoin-based porous organic polymer and preparation method and application thereof | |
| Yuan et al. | Multi-component design and in-situ synthesis of visible-light-driven SnO2/g-C3N4/diatomite composite for high-efficient photoreduction of Cr (VI) with the aid of citric acid | |
| Rahimi et al. | Visible light photocatalytic disinfection of E. coli with TiO2–graphene nanocomposite sensitized with tetrakis (4-carboxyphenyl) porphyrin | |
| Wang et al. | Visible-light-driven photocatalytic degradation of dye and antibiotics by activated biochar composited with K+ doped g-C3N4: Effects, mechanisms, actual wastewater treatment and disinfection | |
| US9828265B2 (en) | Material used in the removal of contaminants from liquid matrices | |
| CN113164867B (en) | Application of fullerene and fullerene derivative composite material in degrading formaldehyde and indoor VOCs or inhibiting bacteria | |
| Du et al. | π-π conjugation driving degradation of aromatic compounds with in-situ hydrogen peroxide generation over Zn2In2S5 grown on nitrogen-doped carbon spheres | |
| CN108043458A (en) | A kind of preparation method and applications of the heterogeneous fenton catalyst of immobilization | |
| Yang et al. | Novel graphene quantum dots modified NH2-MIL-125 photocatalytic composites for effective antibacterial property and mechanism insight | |
| Zargari et al. | An efficient visible light photocatalyst based on tin porphyrin intercalated between TiO 2–graphene nanosheets for inactivation of E. coli and investigation of charge transfer mechanism | |
| ArunaKumari et al. | New insights into the origin of the visible light photocatalytic activity of Fe (III) porphyrin surface anchored TiO 2 | |
| CN113908835A (en) | Preparation and application of active composite material based on non-free-radical efficient mineralization sulfonamide antibiotics | |
| Ali et al. | Effective removal of organic compounds using a novel cellulose acetate coated by PA/g-CN/Ag nanocomposite membranes | |
| Zhang et al. | Anchoring of copper sulfide on cellulose fibers with polydopamine for efficient and recyclable photocatalytic degradation of organic dyes | |
| Yuan et al. | Biomimetic Laccase-Cu2O@ MOF for synergetic degradation and colorimetric detection of phenolic compounds in wastewater | |
| Ahmadi et al. | Investigation on polysulfone blended NH2-MIL125 (Ti) membrane for photocatalytic degradation of Methylene Blue dye | |
| Xiao et al. | Photocatalytic degradation of ciprofloxacin in freshwater aquaculture wastewater by a CNBN membrane: mechanism, antibacterial activity, and cyclability | |
| CN114570406A (en) | Carbon nitride composite photocatalytic material for organic sewage remediation and preparation method thereof | |
| CN109603906A (en) | A kind of anthraquinone-2-sodium/graphene oxide composite photo-catalysis bactericide and its preparation method and application | |
| Adnan et al. | Visible light-enable oxidation and antibacterial of zinc oxide hybrid chitosan photocatalyst towards aromatic compounds treatment | |
| Wang et al. | Highly efficient degradation of rhodamine B by α-MnO2 nanorods | |
| Xue et al. | Supramolecular porphyrin/ZnFe layered double hydroxide heterojunction as multifunctional photocatalytic surface for effective sterilization and degradation: Performance and enhanced mechanism insight | |
| Shu et al. | Novel simulated sunlight-driven NaYF4: Yb, Tm@ MIL-53 (Fe) nanorods photocatalysts for degradation of organic pollutants and enhanced antibacterial activity | |
| Ullah et al. | Novel silver-morphine-functionalized polypropylene (AgPP-mrp) nanocomposite for the degradation of dye removal by multivariate optimization approach | |
| Fatima et al. | Photocatalytic reduction of chromium by titanium metal organic frameworks in the presence of low-molecular-weight organic acids under UV and visible light |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |